ASCO GUIDELINES Bundle

Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475475

Contents of this Issue

Navigation

Page 3 of 9

4 Treatment Recommendation 2.3b ➤ Concurrent weekly cisplatin may be administered with postoperative RT to patients who are considered inappropriate for standard high- dose intermittent cisplatin after a careful discussion of patient preferences and the limited evidence supporting this treatment schedule. (Moderate Recommendation; EB-I-B) Recommendation 3.1 ➤ Elective neck dissection is the preferred approach for patients with oral cavity cancer who require management of the clinically negative neck as outlined in recommendation 1.1a. Elective radiotherapy to a non-dissected neck (50-56 Gy in 25-30 fractions) may be efficacious and should be administered if surgery is not feasible. (Moderate Recommendation; EB-I-B) Recommendation 3.2 ➤ For patients who have undergone ipsilateral neck dissection only and are at substantial risk of contralateral nodal involvement (e.g. tumor of the oral tongue and/or floor of mouth that is T3/4 or approaches midline), contralateral neck radiotherapy should be administered to treat potential microscopic disease. (Moderate Recommendation; EB-I-B) Oropharynx Recommendation 4.1 ➤ Patients with lateralized oropharyngeal carcinoma who are being treated with upfront curative surgery should undergo an ipsilateral neck dissection of levels II-IV. An adequate dissection should include at least 18 lymph nodes. (Moderate Recommendation; EB-I-B) Recommendation 4.2 ➤ Patients with lateralized oropharyngeal cancer who have neck dissection concurrently or before transoral endoscopic head and neck surgery should have ligation of at-risk feeding blood vessels to reduce the severity and incidence of post-operative bleeding. (Moderate Recommendation; EB-L-B)

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx